TriptoBIO ApS: Financial statements 2024
CVR: 43307495
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
TriptoBIO ApS (CVR 43307495) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -562,643 and a net result of DKK -4,449,073 compared with DKK -3,212,101 the year before. Equity in the 2024 report amounted to DKK -7,641,893. The company had 5 employees in the financial year.
- Gross Profit
- DKK -562,643
- Profit/Loss
- DKK -4,449,073
- Equity
- DKK -7,641,893
- Total Assets
- DKK 7,589,895
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -563 t. | -4.4 mio. | -7.6 mio. | 5 |
| 2023 | - | -855 t. | -3.2 mio. | -3.2 mio. | 5 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
TriptoBIO ApS has published its annual report for 2023. Gross profit came to DKK -854,685, and the net result was DKK -3,212,101.
About TriptoBIO ApS
TriptoBIO ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jon Rune Christensen and Johan Andersen-Ranberg. The company is owned by JRC Holding HL ApS and JAR ApS. In 2025, the company reported a gross profit of DKK -54,353 and a net result of DKK -4,175,620 compared with DKK -4,449,073 the year before. Equity in the 2025 report amounted to DKK -11,817,513.